CPRX vs PSX · P/E 18, rev $491.7M vs P/E 17, rev $83.54B
Catalyst Pharmaceuticals Inc (CPRX) versus Phillips 66 (PSX) — a side-by-side from cached financials, not a winner call.
Catalyst Pharmaceuticals Inc (CPRX) is a biotechnology company listed on NASDAQ.
Phillips 66 (PSX) is a oil & gas refining & marketing company listed on NYSE.
Latest reported CPRX revenue for 2024-12-31 was $491.7M. Net income was $163.9M. Revenue was up 23.5% from 2023-12-31 to 2024-12-31. CPRX currently screens at market cap $3.84B and trailing P/E 18.2.
Latest reported PSX revenue for 2026-06-30 was $83.54B. Net income was $4.05B. PSX currently screens at market cap $67.02B and trailing P/E 16.5.
CPRX currently screens at market cap $3.84B and trailing P/E 18.2. PSX currently screens at market cap $67.02B and trailing P/E 16.5.
Not investment advice. Open the CPRX and PSX stock pages for the full models.
Not investment advice.